Business / Finance

RSS

EMS Find inks LOI to acquire Page Out

EMS Find, Inc. today announced that the company has signed a Letter Of Intent ("LOI") to acquire Page Out – interactive platform designed to streamline the emergency response process and provides management with real time status on where and when team members are responding to emergency and dispatch.

23 Jun 2015

Bracket Global, Clintara agree to merge

Bracket Global, LLC and Clintara are pleased to announce the two companies have agreed to combine. Bracket will integrate the Clintara platform of surveillance strategies developed for clinical trials within Bracket's proprietary electronic platform for Clinical Outcome Assessments (eCOA).

23 Jun 2015

Biolin Scientific has announced new Vice President for the Drug Discovery business unit

Biolin Scientific Holding AB has appointed Thais T. Johansen as VP of the Drug Discovery business unit (Sophion), where he replaces Morten Sunesen.

From Biolin Scientific AB 22 Jun 2015

Wockhardt obtains final approval from FDA for marketing 5mg/ 5ml of Oxycodone HCl liquid

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 5mg/ 5ml of Oxycodone HCl liquid which is used in treatment of moderate to severe acute and chronic pain. Wockhardt is launching the product soon and will be amongst the few generic versions of this product in the market.

22 Jun 2015

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Benitec Biopharma is pleased to announce the launch of a new exploratory cellular therapy program including exosome-based delivery utilising the Company's proprietary ddRNAi technology. Entry into these areas have been facilitated by the commencement of a collaboration with UK-based stem cell therapeutics company, ReNeuron.

22 Jun 2015

Advanced Cell Diagnostics raises $22 million in Series C equity financing

Advanced Cell Diagnostics, Inc., a world leader in the field of in situ nucleic acid detection for life science research and clinical diagnostics, announced today that it has raised $22 million in Series C equity financing, led by growth equity investor Summit Partners with participation from Kenson Ventures and existing investors, Morningside Ventures and New Leaf Venture Partners.

From Advanced Cell Diagnostics 22 Jun 2015

Trevelino/Keller selected as ExamMed's principal integrated PR and marketing agency

ExamMed, the only universal healthcare technology platform, offering providers an ideal patient-centered, complete model of care, both virtual and in-office, recently selected Trevelino/Keller as its principal integrated PR and marketing agency.

22 Jun 2015

ImmunoCellular, Pure MHC partner to develop new assay for ICT-107 phase 3 registrational clinical program

ImmunoCellular Therapeutics, Ltd. announced an agreement with Pure MHC, an Emergent Technologies portfolio company, for development of a novel assay for quality control that will be an important component of ImmunoCellular's ICT-107 phase 3 registrational clinical program in newly diagnosed glioblastoma, anticipated to begin in the second half of 2015.

22 Jun 2015

MESA announces acquisition of Sigil

MESA Group Holdings, a Pantheon Healthcare Group company, today announced the acquisition of French diagnostic imaging service provider Sigil. Complementing MESA's recent business expansion into France with its core Multi-Vendor Service (MVS) and Managed Equipment Service (MES) offerings, the acquisition of Sigil will accelerate the development and adoption of more efficient asset management and medical equipment maintenance service solutions for public and private sector hospitals and imaging centres.

22 Jun 2015

Elsevier's first ever Harriet Lane Essay Contest focuses on advancements in pediatric care

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced a call for submissions for the first ever Harriet Lane Essay Contest. Participants will submit a 500-word essay on the advancements in pediatric care as reflected in The Harriet Lane Handbook.

22 Jun 2015

ScinoPharm Taiwan, Raffles PharmaTech collaborate to manufacture Celecoxib

ScinoPharm Taiwan, Ltd. and Raffles PharmaTech announced today the collaboration to manufacture "Celecoxib," a non-steroidal and anti-inflammatory analgesic active pharmaceutical ingredient (API).

22 Jun 2015

New multidisciplinary Centre For Research into Obesity and Related Diseases opens In Sao Paulo

Researchers, clinicians, health educators and policy makers all gathered on May 4th in Sao Paulo, Brazil, as the new Multidisciplinary Centre for Research into Obesity and Related Comorbidities (Cepid-OCRC) was opened at da Universidade Estadual de Campinas (UNICAMP).

From Bruker BioSpin - NMR, EPR and Imaging 22 Jun 2015

ZEISS and University of California Berkeley launch public-private partnership to support brain microscopy Innovation Center

ZEISS announces that it is participating in a new public-private partnership with UC Berkeley as part of the Brain Microscopy Innovation Center (BrainMIC), a component of the Berkeley BRAIN Initiative.

From Carl Zeiss Microscopy GmbH 22 Jun 2015

OphthaliX enters into definitive agreement to purchase Improved Vision Systems

OphthaliX Inc., a clinical-stage company focused on developing therapeutic products for the treatment of ophthalmic disorders and a subsidiary of Can-Fite BioPharma Ltd., announced today it has signed a definitive agreement to acquire Israel-based Improved Vision Systems Ltd. in a stock-for-stock transaction.

19 Jun 2015

Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

Alexza Pharmaceuticals, Inc. today announced that it has updated and amended its ADASUVE (Staccato loxapine) commercial partnerships with Grupo Ferrer Internacional, S.A. and Teva Pharmaceutical Industries Ltd. Ferrer is Alexza's commercial partner for ADASUVE in the European Union, Latin America, the Commonwealth of Independent States and other countries in Europe.

19 Jun 2015

Florida Institute finalizes funding agreement with TransGenex Nanobiotech

The Florida Institute for the Commercialization of Public Research announced today that it has finalized a funding agreement with TransGenex Nanobiotech, Inc., a company that is developing nano-scale technologies for novel, cost-effective diagnostic and therapeutic agents against cancers and other inflammatory diseases.

19 Jun 2015

Hitachi High-Technologies, QIAGEN form new strategic partnership to advance molecular testing

Hitachi High-Technologies Corporation and QIAGEN N.V. have entered into a long-term strategic collaboration involving initiatives to deliver important advances in molecular testing.

From QIAGEN Manchester Limited 18 Jun 2015

Beckman Coulter brings new thinking to new lab challenges at EuroMedLab 2015

Beckman Coulter Diagnostics supports IFCC-EFLM EuroMedLab 2015 with a showcase of solutions to improve workflow for the diagnostics laboratory. Held from 22-24 June 2015 at the Paris Palais des Congrès France, the company demonstrates its dedication to moving the clinical diagnostic lab forward with its total laboratory solution—from automation, chemistry, immunoassay and haematology to microbiology and its new molecular diagnostics system.

From Beckman Coulter Diagnostics 18 Jun 2015

Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

Eli Lilly and Company and Sarah Cannon Research Institute today announced a strategic partnership to co‑develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor. Under the agreement, SCRI will collaborate with Lilly to provide clinical development expertise and program design, as well as medical oversight and trial management. Patient enrollment for the initial Phase II clinical trial is underway.

17 Jun 2015

Allergan agrees to acquire KYTHERA Biopharmaceuticals for $2.1 billion

Allergan plc, a leading global pharmaceutical company, and KYTHERA Biopharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market, today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction valued at $75 per KYTHERA share, or approximately $2.1 billion.

17 Jun 2015

Business / Finance

EMS Find inks LOI to acquire Page Out

Bracket Global, Clintara agree to merge

Biolin Scientific has announced new Vice President for the Drug Discovery business unit

Wockhardt obtains final approval from FDA for marketing 5mg/ 5ml of Oxycodone HCl liquid

Benitec, ReNeuron collaborate to launch new exploratory cellular therapy program

Advanced Cell Diagnostics raises $22 million in Series C equity financing

Trevelino/Keller selected as ExamMed's principal integrated PR and marketing agency

ImmunoCellular, Pure MHC partner to develop new assay for ICT-107 phase 3 registrational clinical program

MESA announces acquisition of Sigil

Elsevier's first ever Harriet Lane Essay Contest focuses on advancements in pediatric care

ScinoPharm Taiwan, Raffles PharmaTech collaborate to manufacture Celecoxib

New multidisciplinary Centre For Research into Obesity and Related Diseases opens In Sao Paulo

ZEISS and University of California Berkeley launch public-private partnership to support brain microscopy Innovation Center

OphthaliX enters into definitive agreement to purchase Improved Vision Systems

Alexza updates, amends ADASUVE (Staccato loxapine) commercial partnerships with Ferrer and Teva

Florida Institute finalizes funding agreement with TransGenex Nanobiotech

Hitachi High-Technologies, QIAGEN form new strategic partnership to advance molecular testing

Beckman Coulter brings new thinking to new lab challenges at EuroMedLab 2015

Lilly, Sarah Cannon Research Institute partner to co‑develop investigational oncology compound

Allergan agrees to acquire KYTHERA Biopharmaceuticals for $2.1 billion

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News